Experienced in PIK3CA-Related Overgrowth Spectrum

Dr. Robert Hopkin

Medical Genetics | Pediatrics
Cincinatti Children's
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 

Experienced in PIK3CA-Related Overgrowth Spectrum
Cincinatti Children's
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Hopkin is a Medical Genetics specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Hopkin is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. His top areas of expertise are Fabry Disease, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Micrognathia, and Orchiectomy.

His clinical research consists of co-authoring 137 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Medical Genetics
Pediatrics
Licenses
Clinical Genetics in OH
Hospital Affiliations
Cincinnati Children's Hospital Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

CHILDREN'S HOSPITAL MEDICAL CENTER
3333 Burnet Ave, Cincinnati, OH 45229
Call: 513-636-4200

Additional Areas of Focus

Dr. Hopkin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease (STAAR)
A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease (STAAR)
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Biological
Study Drug: ST-920
Study Phase: Phase 1/Phase 2
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader- Willi Syndrome
Enrollment Status: Terminated
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drug: RAD011
Study Phase: Phase 2/Phase 3
Phase 3 Open-Label Switch Over Study to Assess Safety, Efficacy & PK of Pegunigalsidase Alfa (PRX-102) 2mg/kg IV Every 4 Weeks for 52 Weeks in Fabry Disease Patients Currently Treated With Enzyme Replacement Therapy Fabrazyme® or Replagal™
Phase 3 Open-Label Switch Over Study to Assess Safety, Efficacy & PK of Pegunigalsidase Alfa (PRX-102) 2mg/kg IV Every 4 Weeks for 52 Weeks in Fabry Disease Patients Currently Treated With Enzyme Replacement Therapy Fabrazyme® or Replagal™
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drug: Pegunigalsidase Alfa
Study Phase: Phase 3
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drugs: PRX-102 (Pegunigalsidase Alfa), Agalsidase Beta
Study Phase: Phase 3
View 3 Less Clinical Trials

137 Total Publications

Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder.
Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder.
Journal: Brain, behavior, & immunity - health
Published: April 19, 2025
View All 137 Publications
Similar Doctors
Advanced in PIK3CA-Related Overgrowth Spectrum
Dr. Francesco Mangano
Neurosurgery | Pediatrics
Advanced in PIK3CA-Related Overgrowth Spectrum
Dr. Francesco Mangano
Neurosurgery | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Francesco Mangano is a Neurosurgery specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Mangano is rated as an Elite provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. His top areas of expertise are Hydrocephalus, Epilepsy, Cortical Dysplasia, Posterior Fossa Decompression, and Laminectomy.

Advanced in PIK3CA-Related Overgrowth Spectrum
Dr. Cameron W. Thomas
Pediatric Neurology | Neurology | Pediatrics
Advanced in PIK3CA-Related Overgrowth Spectrum
Dr. Cameron W. Thomas
Pediatric Neurology | Neurology | Pediatrics
3333 Burnet Avenue, Mlc 2015, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4222
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Cameron Thomas is a Pediatric Neurologist and a Neurologist in Cincinnati, Ohio. Dr. Thomas is rated as a Distinguished provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. His top areas of expertise are Seizures, Epilepsy in Children, Generalized Tonic-Clonic Seizure, and Myotonia Congenita. Dr. Thomas is currently accepting new patients.

Experienced in PIK3CA-Related Overgrowth Spectrum
Dr. Anne M. Slavotinek
Medical Genetics | Pediatrics
Experienced in PIK3CA-Related Overgrowth Spectrum
Dr. Anne M. Slavotinek
Medical Genetics | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anne Slavotinek is a Medical Genetics specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Slavotinek is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Chromosome 13q Deletion, Chromosome 6 Uniparental Disomy, Tetrasomy 9p, and Temple Syndrome. Dr. Slavotinek is currently accepting new patients.

VIEW MORE PIK3CA-RELATED OVERGROWTH SPECTRUM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hopkin's expertise for a condition
ConditionClose
  • Elite
  • Fabry Disease
    Dr. Hopkin is
    Elite
    . Learn about Fabry Disease.
    See more Fabry Disease experts
  • Neurofibromatosis Type 1 (NF1)
    Dr. Hopkin is
    Elite
    . Learn about Neurofibromatosis Type 1 (NF1).
    See more Neurofibromatosis Type 1 (NF1) experts
  • Distinguished
  • CHARGE Syndrome
    Dr. Hopkin is
    Distinguished
    . Learn about CHARGE Syndrome.
    See more CHARGE Syndrome experts
  • Corpus Callosum Agenesis
    Dr. Hopkin is
    Distinguished
    . Learn about Corpus Callosum Agenesis.
    See more Corpus Callosum Agenesis experts
  • Cortical Dysplasia
    Dr. Hopkin is
    Distinguished
    . Learn about Cortical Dysplasia.
    See more Cortical Dysplasia experts
  • Costello Syndrome
    Dr. Hopkin is
    Distinguished
    . Learn about Costello Syndrome.
    See more Costello Syndrome experts
  • Crouzon Syndrome
    Dr. Hopkin is
    Distinguished
    . Learn about Crouzon Syndrome.
    See more Crouzon Syndrome experts
  • Fetal Akinesia Sequence
    Dr. Hopkin is
    Distinguished
    . Learn about Fetal Akinesia Sequence.
    See more Fetal Akinesia Sequence experts
View All 18 Distinguished Conditions
  • Advanced
  • 15q11.2 Microdeletion
    Dr. Hopkin is
    Advanced
    . Learn about 15q11.2 Microdeletion.
    See more 15q11.2 Microdeletion experts
  • 2q37 Deletion Syndrome
    Dr. Hopkin is
    Advanced
    . Learn about 2q37 Deletion Syndrome.
    See more 2q37 Deletion Syndrome experts
  • 3MC Syndrome
    Dr. Hopkin is
    Advanced
    . Learn about 3MC Syndrome.
    See more 3MC Syndrome experts
  • 3p Deletion Syndrome
    Dr. Hopkin is
    Advanced
    . Learn about 3p Deletion Syndrome.
    See more 3p Deletion Syndrome experts
  • 47 XYY Syndrome
    Dr. Hopkin is
    Advanced
    . Learn about 47 XYY Syndrome.
    See more 47 XYY Syndrome experts
  • Aase Syndrome
    Dr. Hopkin is
    Advanced
    . Learn about Aase Syndrome.
    See more Aase Syndrome experts
View All 186 Advanced Conditions
  • Experienced
  • Acro-Pectoro-Renal Field Defect
    Dr. Hopkin is
    Experienced
    . Learn about Acro-Pectoro-Renal Field Defect.
    See more Acro-Pectoro-Renal Field Defect experts
  • Acropectoral Syndrome
    Dr. Hopkin is
    Experienced
    . Learn about Acropectoral Syndrome.
    See more Acropectoral Syndrome experts
  • Adams-Oliver Syndrome
    Dr. Hopkin is
    Experienced
    . Learn about Adams-Oliver Syndrome.
    See more Adams-Oliver Syndrome experts
  • AEC Syndrome
    Dr. Hopkin is
    Experienced
    . Learn about AEC Syndrome.
    See more AEC Syndrome experts
  • Andersen Disease
    Dr. Hopkin is
    Experienced
    . Learn about Andersen Disease.
    See more Andersen Disease experts
  • Aplasia Cutis Congenita
    Dr. Hopkin is
    Experienced
    . Learn about Aplasia Cutis Congenita.
    See more Aplasia Cutis Congenita experts
View All 93 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved